Abbott Laboratories (ETR:ABL)
115.16
-0.66 (-0.57%)
Oct 10, 2025, 5:35 PM CET
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of €198.50 billion as of October 10, 2025. Its market cap has increased by 13.05% in one year.
Market Cap
198.50B
Enterprise Value
204.05B
Revenue
36.71B
Ranking
n/a
PE Ratio
16.74
Stock Price
€115.16
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 198.50B, an increase of 31,096.78%. That is a compound annual growth rate of 10.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 198.50B | 4.75% |
Dec 31, 2024 | 189.49B | 9.61% |
Dec 29, 2023 | 172.88B | -3.48% |
Dec 30, 2022 | 179.12B | -15.60% |
Dec 31, 2021 | 212.23B | 38.39% |
Dec 31, 2020 | 153.36B | 12.04% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Siemens Healthineers AG | 52.54B |
Merck KGaA | 50.48B |
Bayer Aktiengesellschaft | 27.49B |
Fresenius SE & Co. KGaA | 26.87B |
Fresenius Medical Care AG | 13.48B |
Sartorius Aktiengesellschaft | 13.36B |
Fielmann Group AG | 4.17B |
Carl Zeiss Meditec AG | 3.74B |